Status:
RECRUITING
The Study of Association of Helicobacter Infections in Biliary Tract Cancers
Lead Sponsor:
Institute of Liver and Biliary Sciences, India
Conditions:
Biliary Tract Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Biliary tract carcinoma (BTC) includes gallbladder carcinoma, hilar cholangiocarcinoma, and distal cholangiocarcinoma, intrahepatic cholangiocarcinoma. Chronic infections of the biliary tract are majo...
Detailed Description
Biliary tract carcinoma (BTC) includes gallbladder carcinoma, hilar cholangiocarcinoma, and distal cholangiocarcinoma, intrahepatic cholangiocarcinoma. Chronic infections of the biliary tract are majo...
Eligibility Criteria
Inclusion
- Biliary tract carcinoma patients who underwent resection
- Patients undergoing cholecystectomy for benign biliary disease.
- Voluntary healthy liver donors with no gallbladder pathology
- Patients undergoing cholecystectomy for conditions with high risk of malignancy
Exclusion
- Patients who have taken H.pylori eradication previously in last three months.
Key Trial Info
Start Date :
March 31 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 31 2026
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT06909188
Start Date
March 31 2025
End Date
May 31 2026
Last Update
December 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ILBS
New Delhi, National Capital Territory of Delhi, India, 110070